MiNK Therapeutics, Inc. — Director's Dealing 2021

Oct 21, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-13

Reporting Person: Ryan Barbara (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.03	2031-09-15	Common Stock (41745)		Direct

Footnotes

F1: Represents an option to purchase shares of the common stock, which vests in three equal annual installments beginning on April 3, 2022.